Jonathan Sheena, a director at $NTRA, sold 285 shares of the company on 05-13-2026 for an estimated $57,764. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.4% of their shares of this class of stock. Following this trade, they now own 19,541 shares of this class of $NTRA stock.
$NTRA Insider Trading Activity
$NTRA insiders have traded $NTRA stock on the open market 219 times in the past 6 months. Of those trades, 0 have been purchases and 219 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by insiders over the last 6 months:
- STEVEN LEONARD CHAPMAN (CEO AND PRESIDENT) has made 0 purchases and 23 sales selling 194,077 shares for an estimated $44,699,425.
- MATTHEW RABINOWITZ (EXECUTIVE CHAIRMAN) has made 0 purchases and 28 sales selling 207,708 shares for an estimated $39,925,592.
- MICHAEL BURKES BROPHY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 21 sales selling 79,769 shares for an estimated $18,738,853.
- ROELOF BOTHA has made 0 purchases and 11 sales selling 75,000 shares for an estimated $17,708,935.
- SOLOMON MOSHKEVICH (PRESIDENT, CLINICALDIAGNOSTICS) has made 0 purchases and 34 sales selling 53,495 shares for an estimated $12,122,271.
- HERM ROSENMAN has made 0 purchases and 4 sales selling 48,419 shares for an estimated $11,011,477.
- JONATHAN SHEENA has made 0 purchases and 58 sales selling 44,699 shares for an estimated $9,759,305.
- DANIEL RABINOWITZ (SEC. AND CHIEF LEGAL OFFICER) has made 0 purchases and 19 sales selling 43,626 shares for an estimated $9,535,071.
- JOHN FESKO (PRESIDENT, CHIEF BUS. OFFICER) has made 0 purchases and 10 sales selling 26,137 shares for an estimated $6,047,654.
- ROY D. BAYNES has made 0 purchases and 8 sales selling 12,780 shares for an estimated $2,809,688.
- ROWAN E CHAPMAN has made 0 purchases and 3 sales selling 4,488 shares for an estimated $1,084,737.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$NTRA Hedge Fund Activity
We have seen 404 institutional investors add shares of $NTRA stock to their portfolio, and 375 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- COATUE MANAGEMENT LLC added 2,463,008 shares (+1446.1%) to their portfolio in Q4 2025, for an estimated $564,250,502
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,312,887 shares (+12.1%) to their portfolio in Q1 2026, for an estimated $262,564,271
- JPMORGAN CHASE & CO added 1,225,420 shares (+10.5%) to their portfolio in Q4 2025, for an estimated $280,731,467
- FMR LLC added 1,078,266 shares (+73.1%) to their portfolio in Q1 2026, for an estimated $215,642,417
- CITADEL ADVISORS LLC removed 786,720 shares (-87.7%) from their portfolio in Q4 2025, for an estimated $180,229,684
- FARALLON CAPITAL MANAGEMENT LLC removed 707,000 shares (-18.1%) from their portfolio in Q1 2026, for an estimated $141,392,930
- FRED ALGER MANAGEMENT, LLC removed 629,271 shares (-25.7%) from their portfolio in Q4 2025, for an estimated $144,159,693
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$NTRA Revenue
$NTRA had revenues of $696.6M in Q1 2026. This is an increase of 38.82% from the same period in the prior year.
You can track NTRA financials on Quiver Quantitative's NTRA stock page.
You can access data on NTRA stock through the Quiver Quantitative API.
$NTRA Analyst Ratings
Wall Street analysts have issued reports on $NTRA in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 04/14/2026
- Canaccord Genuity issued a "Buy" rating on 12/22/2025
- BTIG issued a "Buy" rating on 12/05/2025
- JP Morgan issued a "Overweight" rating on 11/25/2025
- UBS issued a "Buy" rating on 11/18/2025
To track analyst ratings and price targets for $NTRA, check out Quiver Quantitative's $NTRA forecast page.
$NTRA Price Targets
Multiple analysts have issued price targets for $NTRA recently. We have seen 11 analysts offer price targets for $NTRA in the last 6 months, with a median target of $270.0.
Here are some recent targets:
- Mark Massaro from BTIG set a target price of $250.0 on 05/11/2026
- Daniel Markowitz from Evercore ISI Group set a target price of $270.0 on 05/08/2026
- Brandon Couillard from Wells Fargo set a target price of $220.0 on 05/08/2026
- Casey Woodring from JP Morgan set a target price of $265.0 on 05/08/2026
- Tejas Savant from Morgan Stanley set a target price of $250.0 on 03/03/2026
- Catherine Ramsey from Baird set a target price of $257.0 on 02/27/2026
- Patrick Donnelly from Citigroup set a target price of $300.0 on 01/07/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
